A lesA million-dollar question every biotech/medtech entrepreneur faces.

As I get ready to attend #BIOEQUITY in San Sebastián this Sunday on behalf of Attgeno, I wanted to share a quick insight on pre-money valuation and how we should think about it.

Looking forward to seeing many of you there! 👋